S L Slager
Overview
Explore the profile of S L Slager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tracy S, Maurer M, Witzig T, Drake M, Ansell S, Nowakowski G, et al.
Blood Cancer J
. 2017 Aug;
7(8):e595.
PMID: 28841207
We evaluated whether vitamin D insufficiency (VDI; 25(OH)D <20 ng/ml) was associated with adverse outcomes among follicular lymphoma (FL) patients using an observational prospective cohort study of 642 FL patients...
2.
Manso B, Wenzl K, Asmann Y, Maurer M, Manske M, Yang Z, et al.
Blood Cancer J
. 2017 Apr;
7(4):e553.
PMID: 28430174
No abstract available.
3.
Rossille D, Azzaoui I, Feldman A, Maurer M, Laboure G, Parrens M, et al.
Leukemia
. 2016 Dec;
31(4):988-991.
PMID: 28035137
No abstract available.
4.
Barrio S, Shanafelt T, Ojha J, Chaffee K, Secreto C, Kortum K, et al.
Leukemia
. 2016 Jul;
31(1):170-176.
PMID: 27469216
High-count monoclonal B-cell lymphocytosis (MBL) is an asymptomatic expansion of clonal B cells in the peripheral blood without other manifestations of chronic lymphocytic leukemia (CLL). Yearly, 1% of MBLs evolve...
5.
Novak A, Asmann Y, Maurer M, Wang C, Slager S, Hodge L, et al.
Blood Cancer J
. 2015 Aug;
5:e346.
PMID: 26314988
Lack of remission or early relapse remains a major clinical issue in diffuse large B-cell lymphoma (DLBCL), with 30% of patients failing standard of care. Although clinical factors and molecular...
6.
Solomon B, Chaffee K, Moreira J, Schwager S, Cerhan J, Call T, et al.
Leukemia
. 2015 Aug;
30(2):331-6.
PMID: 26310541
It is unknown whether individuals with monoclonal B-cell lymphocytosis (MBL) are at risk for adverse outcomes associated with chronic lymphocytic leukemia (CLL), such as the risk of non-hematologic cancer. We...
7.
Asmann Y, Maurer M, Wang C, Sarangi V, Ansell S, Feldman A, et al.
Blood Cancer J
. 2014 Nov;
4:e256.
PMID: 25360902
No abstract available.
8.
Cozen W, Timofeeva M, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, et al.
Nat Commun
. 2014 Jun;
5:3856.
PMID: 24920014
Recent genome-wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here...
9.
Greenberg A, Lee A, Serie D, McDonnell S, Cerhan J, Liebow M, et al.
Leukemia
. 2012 Sep;
27(2):515-6.
PMID: 22945773
No abstract available.
10.
Moreira J, Rabe K, Cerhan J, Kay N, Wilson J, Call T, et al.
Leukemia
. 2012 Jul;
27(1):136-41.
PMID: 22781591
Although the risk of progression from monoclonal B-cell lymphocytosis (MBL) to chronic lymphocytic leukemia (CLL) has been well characterized, it is unknown whether other common complications associated with CLL, such...